This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-26

Study Completion Date

2019-04-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study was to investigate if AmLactin® Rapid Relief improves the skin through desquamation and moisturization via D-SQUAME analysis. AmLactin® Rapid Relief is an over-the-counter cosmetic.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin

NCT03093597

Xerosis Xerosis Cutis Dry Skin; Eczema

COMPLETED NA

A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects With Dry or Sensitive Skin

NCT06929988

Dry Skin Sensitive Skin

NOT_YET_RECRUITING NA

Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment

NCT00644917

Healthy

COMPLETED PHASE1

A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects With Dry and Sensitive Skin.

NCT06489418

Dry Skin Sensitive Skin

COMPLETED NA

Moisturizing Effect of Two Dexpanthenol Formulations

NCT00839280

Skin Abnormalities

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Skin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Upon enrollment, each subject received a randomization code, indicating which leg the study product had to be applied (the other leg received no study product). Each subject in this study served as her own control.

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Left Leg: AmLactin® Rapid Relief / Right Leg: No Treatment

AmLactin® Rapid Relief, BID application for 14 days on left leg and no treatment on right leg

Group Type EXPERIMENTAL

AmLactin® Rapid Relief

Intervention Type OTHER

AmLactin® Rapid Relief, BID application for 14 days. AmLactin is an over-the-counter cosmetic.

Left Leg: No Treatment / Right Leg: AmLactin® Rapid Relief

AmLactin® Rapid Relief, BID application for 14 days on right leg and no treatment on left leg

Group Type EXPERIMENTAL

AmLactin® Rapid Relief

Intervention Type OTHER

AmLactin® Rapid Relief, BID application for 14 days. AmLactin is an over-the-counter cosmetic.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AmLactin® Rapid Relief

AmLactin® Rapid Relief, BID application for 14 days. AmLactin is an over-the-counter cosmetic.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy female (confirmed by medical history) with Fitzpatrick skin types I-VI
* dry, rough skin on the anterior shins (defined as Grade 3-4 on the dermatologist evaluation of the skin);

Exclusion Criteria

\- Had any visible skin disease at the assessment site which, in the opinion of the Investigator, would interfere with the evaluation of the test site

Minimum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes